Ursprung des Netzwerks ersten Grades von Shinji Hatta
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shinji Hatta
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| STANDEX INTERNATIONAL CORPORATION | Electronic Equipment/Instruments | Director of Finance/CFO | |
| DAI-ICHI LIFE HOLDINGS, INC. | Life/Health Insurance | Director/Board Member | |
| Veranova LP | Corporate Officer/Principal | ||
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Thunderbird School of Global Management | College/University | Graduate Degree | |
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Pharmaceuticals: Major | Chief Executive Officer | |
| PENTAIR PLC | Industrial Machinery | Comptroller/Controller/Auditor | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| MITSUBISHI HEAVY INDUSTRIES, LTD. | Aerospace & Defense | Director/Board Member | |
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Electrical Products | Director/Board Member | |
| ASAHI GROUP HOLDINGS, LTD. | Beverages: Alcoholic | Director/Board Member | |
| NITERRA CO., LTD. | Auto Parts: OEM | Director/Board Member | |
Eisai SAS
 Eisai SAS Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai SAS is a French pharmaceutical company founded in 1996. The company is based in Courbevoie, France and strives to improve the lives of those who could benefit from their medicines. Eisai focuses its research on oncology and neurology, two areas presenting challenges in terms of public health. The company is committed to the fight against serious diseases, alongside patients, healthcare professionals, and public authorities. | Pharmaceuticals: Major | Chairman | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Nagashima Ohno & Tsunematsu
 Nagashima Ohno & Tsunematsu Miscellaneous Commercial ServicesCommercial Services Nagashima Ohno & Tsunematsu is a leading general law firm in Japan that provides comprehensive legal services to deal with various legal issues facing companies. The private company is based in Tokyo, Japan. The firm was established in 2000 by lawyers who belonged to the Nagashima/Ono Law Office and Tsuneomatsu Yanase Sekine Law Office. The firm specializes in providing legal and tax support to corporate founders and officers for the management, operation, business succession, inheritance, and wills of domestic and overseas assets. The firm has a strong presence in the Asian region, particularly in Singapore, Bangkok, Ho Chi Minh, Hanoi, Jakarta, and Shanghai. The firm also has a New York office that provides comprehensive legal advice to Japanese and American clients. The firm's intellectual property-related practices include traditional intellectual financial transactions, large M&A and finance projects involving intellectual property, and intellectual property issues. The firm also has a strong dispute resolution team that handles large and complex projects. The firm's medicine and healthcare team provides a wide range of seamless responses based on the latest trends in the regulation environment and practical trends. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Brandeis University | College/University | Doctorate Degree | |
| Lycoming College | College/University | Undergraduate Degree | |
| University of Bridgeport | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Barcelona | College/University | Doctorate Degree | |
| University of Hitotsubashi | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Medical College of Wisconsin, Inc. | College/University | Corporate Officer/Principal | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Corporate Officer/Principal | |
Eisai Farmacéutica SA
 Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the company was founded in 2001. The CEO is Gary Bryan Hendler. | Pharmaceuticals: Major | Chief Executive Officer | |
Eisai GmbH
 Eisai GmbH Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai GmbH is a German pharmaceutical company that specializes in research and development of innovative treatments for neurological and oncological diseases. The company is based in Frankfurt, Germany. The CEOs of the company are Gary Bryan Hendler, Nicholas Conrad Burgin. | Pharmaceuticals: Major | Chief Executive Officer | |
| Tokyo Bar Association | Director/Board Member | ||
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Hospital/Nursing Management | Corporate Officer/Principal | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
| Drexel University College of Medicine | College/University | Doctorate Degree | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
StandexMeder Electronics GmbH
 StandexMeder Electronics GmbH Electrical ProductsProducer Manufacturing Part of Standex International Corp., StandexMeder Electronics GmbH designs, manufactures and markets reed switches, relays, sensors and other products. The company is based in Singen, Germany. The CEOs of the German company are John Meeks, Ademir Sarcevic, Rainer Hombeck. | Electrical Products | Chief Executive Officer | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| DAISHI HOKUETSU FINANCIAL GROUP, INC. | Major Banks | Director/Board Member | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 26 |
| Japan | 12 |
| Spanien | 5 |
| Vereinigtes Königreich | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 14 |
| Finance | 5 |
| Producer Manufacturing | 5 |
| Commercial Services | 4 |
Operativ
| Corporate Officer/Principal | 39 |
| Director/Board Member | 36 |
| Independent Dir/Board Member | 18 |
| Chief Executive Officer | 7 |
| Chief Tech/Sci/R&D Officer | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Shinji Hatta
- Unternehmensverbindungen
